MELINTA THERAPEUTICS, INC. /NEW/ — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/faee69ee-751e-4941-8fea-a41019d3254f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-157.2M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002907 |
| FY 2017 | $-58.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005947 |
| FY 2016 | $-73.9M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-005947 |
| FY 2015 | $-78.7M | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-005947 |
| FY 2014 | $-61.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-002719 |
| FY 2013 | $-45.0M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-000446 |
| FY 2012 | $-24.2M | 2012-01-01 – 2012-12-31 | evidence 0001564590-14-000446 |
| FY 2011 | $-21.2M | 2011-01-01 – 2011-12-31 | evidence 0001564590-14-000446 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MELINTA THERAPEUTICS, INC. /NEW/ — all facts · Revenue · Operating Income